Angiotensin II type 1 receptor blockers

被引：391

作者：

Burnier, M ^{[1
]}

机构：

[1] CHU Vaudois, Div Hypertens & Vasc Med, CH-1011 Lausanne, Switzerland

来源：

CIRCULATION | 2001年 / 103卷 / 06期

关键词：

angiotensin; hypertension; heart failure; antihypertensive agents;

D O I：

10.1161/01.CIR.103.6.904

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：904 / 912

页数：9

共 121 条

[1]

Andersson Ove K., 1998, Blood Pressure, V7, P53

[2] ADDITIVE EFFECTS OF COMBINED ANGIOTENSIN-CONVERTING ENZYME-INHIBITION AND ANGIOTENSIN-II ANTAGONISM ON BLOOD-PRESSURE AND RENIN RELEASE IN SODIUM-DEPLETED NORMOTENSIVES [J].

AZIZI, M ;

CHATELLIER, G ;

GUYENE, TT ;

MURIETAGEOFFROY, D ;

MENARD, J .

CIRCULATION, 1995, 92 (04) :825-834

[3] CHRONIC KININ RECEPTOR BLOCKADE ATTENUATES THE ANTIHYPERTENSIVE EFFECT OF RAMIPRIL [J].

BAO, G ;

GOHLKE, P ;

QADRI, F ;

UNGER, T .

HYPERTENSION, 1992, 20 (01) :74-79

[4] Augmented short- and long-term hemodynamic and hormonal effects of an angiotensin receptor blocker added to angiotensin converting enzyme inhibitor therapy in patients with heart failure [J].

Baruch, L ;

Anand, I ;

Cohen, IS ;

Ziesche, S ;

Judd, D ;

Cohn, JN .

CIRCULATION, 1999, 99 (20) :2658-2664

[5] Valsartan, a new angiotensin II receptor antagonist: A double-blind study comparing the incidence of cough with lisinopril and hydrochlorothiazide [J].

Benz, J ;

Oshrain, C ;

Henry, D ;

Avery, C ;

Chiang, YT ;

Gatlin, M .

JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 37 (02) :101-107

[6] CLONING AND CHARACTERIZATION OF A HUMAN ANGIOTENSIN-II TYPE-1 RECEPTOR [J].

BERGSMA, DJ ;

ELLIS, C ;

KUMAR, C ;

NUTHULAGANTI, P ;

KERSTEN, H ;

ELSHOURBAGY, N ;

GRIFFIN, E ;

STADEL, JM ;

AIYAR, N .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 183 (03) :989-995

[7] Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy, tolerability and safety compared to an angiotensin-converting enzyme inhibitor, lisinopril [J].

Black, HR ;

Graff, A ;

Shute, D ;

Stoltz, R ;

Ruff, D ;

Levine, J ;

Shi, Y ;

Mallows, S .

JOURNAL OF HUMAN HYPERTENSION, 1997, 11 (08) :483-489

[8] Pharmacokinetics of eprosartan in healthy subjects, patients with hypertension, and special populations [J].

Bottorff, MB ;

Tenero, DM .

PHARMACOTHERAPY, 1999, 19 (04) :73S-78S

[9] EFFECTS OF BRADYKININ B-2 RECEPTOR ANTAGONISM ON THE HYPOTENSIVE EFFECTS OF ACE-INHIBITION [J].

BOUAZIZ, H ;

JOULIN, Y ;

SAFAR, M ;

BENETOS, A .

BRITISH JOURNAL OF PHARMACOLOGY, 1994, 113 (03) :717-722

[10]

Bremner AD, 1997, CLIN EXP HYPERTENS, V19, P1263

← 1 2 3 4 5 6 7 8 9 10 →